Back to SGMT

Spruce Street Capital LP → SGMT

Spruce Street Capital LP SGMT Position History

Sagimet Biosciences Inc. • Healthcare

Quarters held
1
Latest value
$13.8M
Q3 2026
Peak value
$13.8M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$13.8M1.40M——

Other funds holding SGMT

Other Spruce Street Capital LP positions

KNSA

KINIKSA PHARMACEUTICALS INTL

$68.5M
KNSA

KINIKSA PHARMACEUTICALS INTL

$58.7M
RLAY

RELAY THERAPEUTICS INC

$55.8M
RLAY

RELAY THERAPEUTICS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$44.7M
RLMD

RELMADA THERAPEUTICS INC

$44.2M
RLMD

RELMADA THERAPEUTICS INC

$43M